Loading clinical trials...
Loading clinical trials...
A Prospective, Open-label, Single-arm, Multi-center, Pilot Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Unilateral or Bilateral Temporal Lobe Epilepsy
Conditions
Interventions
NaviFUS System
Locations
3
United States
Stanford University School of Medicine
Palo Alto, California, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
University of Virginia School of Medicine
Charlottesville, Virginia, United States
Start Date
September 13, 2024
Primary Completion Date
December 31, 2026
Completion Date
May 31, 2027
Last Updated
April 9, 2026
NCT02531880
NCT06097195
NCT06315322
NCT07505004
NCT06794606
NCT06700356
Lead Sponsor
NaviFUS Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions